Top movers in Wednesday's pre-market session The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Let's uncover which stocks are experiencing notable gaps during today's session. The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.
Which stocks are gapping on Thursday? The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q2 2024 ATNM stock results show that Actinium Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment FDA rejects Actinium Pharmaceuticals' Phase 3 SIERRA trial for Iomab-B's Biologics License Application due to inadequate support despite achieving a statistically significant primary endpoint. Actinium to conduct a new head-to-head study, focusing on r/r AML treatment without crossover allowances.
3 Under-$10 Biotech Stocks That Could Make You Rich Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis.
3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns These are the clinical-stage biotech stocks to buy, as they represent companies with an attractive product pipeline.
Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials.
3 Cheap Biotech Stocks to Buy Now: May 2024 Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market.
ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q1 2024 ATNM stock results show that Actinium Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
High-Risk, High-Reward: Little-Known Biotech Stock ATNM Could Soar on Breakthrough Cancer Treatment ATNM stock offers moonshot or crash-landing possibilities as Actinium Pharmaceuticals works relentlessly to advance life-changing treatments.
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
Actinium Pharma – Pivotal Results From Key New Drug In The Fight Against Cancer Sandesh Seth, CEO & Chairman of the Board of Actinium Pharmaceuticals (
NASDAQ: ATNM ), was recently a guest on Benzinga’s All-Access.
